Your session is about to expire
← Back to Search
Palliative Care for Parkinson's Disease (COPE-PD Trial)
N/A
Recruiting
Led By Benzi Kluger, MD
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Over age 40 years and diagnosed with PD or other causes of parkinsonism, such as progressive supranuclear palsy, multiple system atrophy and Lewy Body Dementia by their community neurologist.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, 9, 12 months
Awards & highlights
COPE-PD Trial Summary
This trial will test if palliative care training for doctors and telemedicine support services improve quality of life for patients with Parkinson's disease and Lewy Body Dementia.
Who is the study for?
This trial is for people over 40 with Parkinson's disease or related conditions like progressive supranuclear palsy, multiple system atrophy, and Lewy Body Dementia. It's not for those who can't commit to the study, need palliative care for other illnesses like advanced cancer, or are already receiving palliative or hospice care.Check my eligibility
What is being tested?
The study tests how effective it is when community doctors get training in palliative care and patients along with their caregivers receive support through telemedicine. Palliative care aims to improve life quality by easing physical pain, depression, social issues, and spiritual needs using technology.See study design
What are the potential side effects?
Since this trial focuses on non-medical interventions like education and telemedicine support services rather than drugs or medical procedures, traditional side effects are not a concern here.
COPE-PD Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 40 and diagnosed with Parkinson's or a similar condition.
COPE-PD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3, 6, 9, 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, 9, 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Quality of Life: Alzheimer's Disease (QOL-AD)
Zarit Caregiver Burden Interview short form (ZBI)
Secondary outcome measures
Carepartner Measures (FACIT-SP 12)
Carepartner Measures Hospital Anxiety and Depression Scale
Patient Measures (FACIT-SP 12)
+3 moreOther outcome measures
Qualitative Interviews: Carepartner (Health Economic data)
Qualitative Interviews: Carepartner (Validate data)
Qualitative Interviews: Clinician
+2 moreCOPE-PD Trial Design
2Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Community neurologists provide their usual care to enrolled participants. The clinicians may utilize other community resources to support patients and families as per their usual practice.
Group II: Online Community-Supported Palliative Care InterventionExperimental Treatment1 Intervention
Community neurologists get training in palliative care via teleconferences (ECHO model), in addition to other support from our team. Patients and carepartners will also have access to additional support services when their providers enter the intervention (Online support groups, tailored education)
Find a Location
Who is running the clinical trial?
University of RochesterLead Sponsor
845 Previous Clinical Trials
534,307 Total Patients Enrolled
University of Colorado, DenverOTHER
1,752 Previous Clinical Trials
2,164,889 Total Patients Enrolled
Stanford UniversityOTHER
2,408 Previous Clinical Trials
17,342,702 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a serious illness that needs comfort care, like metastatic cancer.I am currently receiving care to ease symptoms or hospice services.I am willing and able to follow the study's procedures.I am over 40 and diagnosed with Parkinson's or a similar condition.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Online Community-Supported Palliative Care Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Parkinson's Disease Patient Testimony for trial: Trial Name: NCT05222386 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger